Clinical Medication Decision Support System

Abstract

The invention discloses a clinical medication decision support system which relates to the field of medical systems. The system comprises a standard treatment medication module, a medication safety reviewing module and a prescription monitoring and warning module, wherein the standard treatment medication module is used for providing diagnosis and treatment reference information and a medication reference scheme according to pathology and physiology information of a patient, so that a doctor can make a prescription; the medication safety reviewing module is used for reviewing the medication safety condition of the patient according to the prescription and generating a reviewing log; and the prescription monitoring and warning module is used for estimating the prescription and generating warning information according to the reviewing log. The system can automatically provide the medication scheme according to the pathology and physiology information of the patient, assist in the doctor to make the prescription, review the safety of the prescription, estimate the prescription and conduct warning on the reviewing result, thus remarkably improving the security, normalization and standardization of clinical medication; and furthermore, by virtue of an antibacterial agent management module, the effective management and monitoring on antibacterial agents are realized, and thus the safety of the clinical medication is further improved.

Description

technical field [0001] The invention relates to the technical field of medical systems, in particular to a clinical medication decision support system. Background technique [0002] In my country, deepening the reform of the medical and health system is a systematic project involving a wide range of areas and great difficulty. On the one hand, my country's medical resources are in short supply, "seeing a doctor is difficult and expensive". For example, there are 10 million epilepsy patients in my country, and there are 400,000 new cases every year, but in fact more than 40% of them have never received treatment. About 35% of people receive informal treatment; on the other hand, the government and the people are paying for "over-diagnosis and drug abuse". The economic loss caused by the abuse of antibiotics alone amounts to more than one billion yuan. [0003] SFDA Drug Evaluation Center investigated the treatment of watery diarrhea in children in 26 hospitals in Beijing, Wuh...

AI Technical Summary

Problems solved by technology

However, the current similar drug safety monitoring systems generally have single functions, which are difficult to meet the application requirements.

Images